| scholarly article | Q13442814 |
| P50 | author | Hector R. Wong | Q37371526 |
| P2093 | author name string | Hans J Vogel | |
| Brent W Winston | |||
| Beata Mickiewicz | |||
| P2860 | cites work | Nitric oxide synthases in mammals | Q24528695 |
| HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
| Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
| Clinical conditions associated with urinary excretion of 2-hydroxybutyric acid | Q28320230 | ||
| The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection | Q28330147 | ||
| An introduction to ROC analysis | Q29299877 | ||
| 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
| Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis | Q30493116 | ||
| Targeted profiling: quantitative analysis of 1H NMR metabolomics data | Q31047473 | ||
| Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study | Q34115285 | ||
| Pediatric risk of mortality (PRISM) score | Q34164023 | ||
| 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma | Q34311681 | ||
| International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics | Q34382371 | ||
| PRISM III: an updated Pediatric Risk of Mortality score | Q34389009 | ||
| Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. | Q34605888 | ||
| Effects of β-hydroxy-β-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats | Q34622685 | ||
| The clinical evaluation of renal function. | Q34934761 | ||
| In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia | Q35044830 | ||
| Lactic acidosis in critical illness | Q35224786 | ||
| Early Reversal of Pediatric-Neonatal Septic Shock by Community Physicians Is Associated With Improved Outcome | Q35549077 | ||
| Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis | Q35809534 | ||
| The influence of developmental age on the early transcriptomic response of children with septic shock | Q35876790 | ||
| Pediatric sepsis and multiorgan dysfunction syndrome: progress and continued challenges | Q37882141 | ||
| Hepatitis C virus infection diagnosis using metabonomics. | Q39910291 | ||
| Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit | Q41461494 | ||
| Readmission and late mortality after pediatric severe sepsis | Q41997960 | ||
| Role of early fluid resuscitation in pediatric septic shock | Q42071311 | ||
| Paediatric logistic organ dysfunction (PELOD) score | Q43474590 | ||
| World Federation of Pediatric Intensive Care and Critical Care Societies: Global Sepsis Initiative | Q43529340 | ||
| A metabonomic approach to early prognostic evaluation of experimental sepsis by (1)H NMR and pattern recognition | Q46074195 | ||
| A metabonomic approach to early prognostic evaluation of experimental sepsis | Q46601509 | ||
| Dietary protein or arginine deficiency impairs constitutive and inducible nitric oxide synthesis by young rats | Q48170072 | ||
| The Pediatric Risk of Mortality III--Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. | Q48591607 | ||
| The epidemiology of severe sepsis in children in the United States. | Q50710556 | ||
| Sequential cardiopulmonary variables of infants and children in septic shock. | Q54471771 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| A metabolomic approach for diagnosis of experimental sepsis | Q57096834 | ||
| Protein metabolism in different types of skeletal muscle during early and late sepsis in rats | Q69563690 | ||
| Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shock | Q70107552 | ||
| Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis | Q70498319 | ||
| Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study | Q73718092 | ||
| Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics | Q79813217 | ||
| A clinical profile of shock in children in Punjab, India | Q80065696 | ||
| Management of septic shock | Q84031865 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| septic shock | Q1765564 | ||
| metabolomics | Q12149006 | ||
| P304 | page(s) | 967-976 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality | |
| P478 | volume | 187 |
| Q89783351 | 1H NMR Based Metabolomics in Human Sepsis and Healthy Serum |
| Q51815621 | Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors. |
| Q38204194 | Applying metabolomics to uncover novel biology in ARDS. |
| Q55262082 | Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study. |
| Q38277169 | Beyond single-nucleotide polymorphisms: genetics, genomics, and other 'omic approaches to acute respiratory distress syndrome |
| Q58570759 | Biomarker Phenotype for Early Diagnosis and Triage of Sepsis to the Pediatric Intensive Care Unit |
| Q38241694 | Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment |
| Q58576665 | Cohort profile of the Biomarkers of Acute Serious Illness in Children (BASIC) study: a prospective multicentre cohort study in critically ill children |
| Q34490041 | Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis |
| Q35153451 | Developing a clinically feasible personalized medicine approach to pediatric septic shock |
| Q36040796 | Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis. |
| Q92563885 | Diagnosis of Bovine Respiratory Disease in feedlot cattle using blood 1H NMR metabolomics |
| Q36070766 | Differential expression of the Nrf2-linked genes in pediatric septic shock. |
| Q34587242 | Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock |
| Q34692311 | Discrimination of sepsis stage metabolic profiles with an LC/MS-MS-based metabolomics approach |
| Q48249825 | Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia |
| Q33584763 | Extensive alterations of blood metabolites in pediatric cerebral malaria |
| Q38181708 | Future clinical applications of genomics for acute respiratory distress syndrome |
| Q40210673 | Generalizable Biomarkers in Critical Care: Toward Precision Medicine |
| Q90683631 | How could metabolomics change pediatric health? |
| Q40285651 | Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP. |
| Q38697751 | In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine. |
| Q37226278 | Increased extracellular heat shock protein 90α in severe sepsis and SIRS associated with multiple organ failure and related to acute inflammatory-metabolic stress response in children |
| Q35122587 | Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit |
| Q62618379 | Low-Field, Benchtop NMR Spectroscopy as a Potential Tool for Point-of-Care Diagnostics of Metabolic Conditions: Validation, Protocols and Computational Models |
| Q90558322 | MetaBridge: An Integrative Multi-Omics Tool for Metabolite-Enzyme Mapping |
| Q33603672 | Metabolic Profiling in Patients with Pneumonia on Intensive Care |
| Q55317384 | Metabolic Profiling of Amino Acids Associated with Mortality in Patients with Acute Paraquat Poisoning. |
| Q30654390 | Metabolic Profiling of Children Undergoing Surgery for Congenital Heart Disease |
| Q38845332 | Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis. |
| Q45964993 | Metabolites Associated With Malnutrition in the Intensive Care Unit Are Also Associated With 28-Day Mortality. |
| Q38657101 | Metabolome alterations in severe critical illness and vitamin D status. |
| Q37534631 | Metabolomic derangements are associated with mortality in critically ill adult patients |
| Q39386206 | Metabolomics as a Driver in Advancing Precision Medicine in Sepsis. |
| Q46104715 | Metabolomics in the diagnosis of sepsis |
| Q38551411 | Metabolomics: Applications and Promise in Mycobacterial Disease. |
| Q26764983 | Metabonomics and intensive care |
| Q37739000 | Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis. |
| Q41715648 | Monitoring neonatal fungal infection with metabolomics. |
| Q38202767 | New diagnostic possibilities in systemic neonatal infections: metabolomics |
| Q39382251 | Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock |
| Q38830793 | Pathogenic, immunologic, and clinical aspects of sepsis - update 2016. |
| Q90727665 | Plasma metabolomics and clinical predictors of survival differences in COPD patients |
| Q33582467 | Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia |
| Q60926108 | Plasma mitochondrial DNA and metabolomic alterations in severe critical illness |
| Q37625638 | Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis. |
| Q26798603 | Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance |
| Q57174545 | Precision Medicine for Neonatal Sepsis |
| Q30903618 | Preprocessing of NMR metabolomics data |
| Q35840652 | Prognosis Biomarkers of Severe Sepsis and Septic Shock by 1H NMR Urine Metabolomics in the Intensive Care Unit. |
| Q43438772 | Prognostic markers for pediatric septic shock: which ones, when, and how? |
| Q30278453 | Research as a Standard of Care in the PICU. |
| Q37249625 | Role of biomarkers in sepsis care. |
| Q38669414 | Sepsis reconsidered: Identifying novel metrics for behavioral landscape characterization with a high-performance computing implementation of an agent-based model |
| Q43141134 | Sepsis without SIRS is still sepsis. |
| Q49561103 | Septic Shock Non-Survivors have Persistently Elevated Acylcarnitines Following Carnitine Supplementation. |
| Q112281948 | Systemic inflammation and metabolic disturbances underlie inpatient mortality among ill children with severe malnutrition |
| Q36181988 | The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology. |
| Q35120147 | The temporal version of the pediatric sepsis biomarker risk model |
| Q37303539 | Time-resolved metabolomics analysis of individual differences during the early stage of lipopolysaccharide-treated rats |
| Q102211016 | Title NMR-based metabolic profiling provides diagnostic and prognostic information in critically ill children with suspected infection |
| Q38208579 | Update in pediatric lung disease 2013. |
| Q35199001 | Update in sepsis and pulmonary infections 2013. |
| Q46316924 | Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis |
| Q37736743 | Urine metabolomics in neonates with late-onset sepsis in a case-control study |
Search more.